ERBB2 and breast cancer: Lymphocyte-predominant BC cases, which have >50% of stromal area infiltrated by TILs, account for about 11% of all invasive breast carcinomas [113] Several studies did show that TILs are more frequently observed in high-grade lesions, in TNBC and HER-2 positive BC [114,115].